Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Nova Mentis Life Science Corp. C.LIB

Nova Mentis Life Science Corp is a Canadian-based company focused on building and supporting a diversified portfolio of health and wellness businesses. Through its subsidiary, the company is focused on exploring the anti-inflammatory effects of psilocybin in underexplored metabolic indications such as obesity and diabetes and providing a Health Canada Standard Licensed facility focused on the cultivation of AAAA premium, small batch, terpene rich dominant cultivars cured to perfection.


CSE:LIB - Post by User

Comment by businessprofon May 22, 2018 11:10am
72 Views
Post# 28063331

RE:RE:News out

RE:RE:News out
This is indeed great news!  Yet another member of the LIB team with a stellar background and zero evidence of involvement with fallen penny plays.   This just continues to tell the story of LIB – a great business model backed by great people.  I for one always look at management when I invest in penny plays.  If the team has been involved in previous penny stocks that did nothing but crash and burn, I steer clear.  If the team has been involved in large scale profit earning companies with stellar reputations at stake, odds are, the company is set to earn profit or such a caliber of person would not go near it, like Jamie Pearson.  Look this woman up.  She is a rock star in this industry and she has chosen to work with LIB.  Do your DD on the team running LIB – there’s no way this company is going anywhere but UP!!!  As for the Attestation of Readiness Review stage for Just Kush mentioned in this latest release, as far as I can tell from previous applicants licensed with David Hyde, this is the stage where the license could be granted at any time, even amidst this review.  And after JK, we have North Road, which is gonna be MASSIVE!

This stock is so cheap it's ridiculous.  It’s still being heavily manipulated with these little nonsense bids and the mysterious little fills from the same brokerage just to bring the price down and scare away the longs.   Just remember, the brokers will only waste their time manipulating a stock like that if they believe it to be undervalued to be begin with.  We should all be thankful for being able to add at these price levels.

Michelle…the small caps have been doing their own thing for months.  WEED was doing nothing when LIB jumped back into the 40s, and then once again, we let the manipulators scare away a bunch of longs.  My point is, the correlation is barely there.  The big 3 will do their own thing and the small caps are going to be relatively stable at these levels until licenses come through.  Having said that, as easily as the manipulators can play with the price, the low volume means it could jump at any time, just as easily.  I keep telling people this, and then it happened a few weeks ago when we jumped into the 40s.  This is why I like that LIB is typically a low volume stock.  We can move big when big news comes.  Today’s news obviously isn’t big news, but it’s definitely good news.  And we are surely at the bottom at these levels.  With the small caps on their own paths now, investors just need to pick and choose the ones that actually have good management and a business model that separates them from the rest of the many, many ACMPR late stage applicants.  The small caps dropped back down because the market became saturated with ACMPR late stage penny plays, at which point, the best ones to go with are the ones that will differentiate themselves in a sea of producers - LIB is clearly the #1 choice in this category as they are so much more than just a producer.
<< Previous
Bullboard Posts
Next >>